These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 3793503)
1. Applied principles of radiopharmaceutical use in therapy. Spencer RP Int J Rad Appl Instrum B; 1986; 13(4):461-3. PubMed ID: 3793503 [TBL] [Abstract][Full Text] [Related]
2. Auger radiation targeted into DNA: a therapy perspective. Buchegger F; Perillo-Adamer F; Dupertuis YM; Delaloye AB Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1352-63. PubMed ID: 16896663 [TBL] [Abstract][Full Text] [Related]
3. Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons. Aghevlian S; Boyle AJ; Reilly RM Adv Drug Deliv Rev; 2017 Jan; 109():102-118. PubMed ID: 26705852 [TBL] [Abstract][Full Text] [Related]
4. Steps towards cancer therapy with radionuclides--a review including radiation biophysical aspects. Kampf G Radiobiol Radiother (Berl); 1990; 31(3):215-29. PubMed ID: 2201055 [TBL] [Abstract][Full Text] [Related]
5. The radiobiology of targeted radiotherapy. Wheldon TE; O'Donoghue JA Int J Radiat Biol; 1990 Jul; 58(1):1-21. PubMed ID: 1973428 [TBL] [Abstract][Full Text] [Related]
7. Radiation absorbed dose estimates at the cellular level for some electron-emitting radionuclides for radioimmunotherapy. Jungerman JA; Yu KH; Zanelli CI Int J Appl Radiat Isot; 1984 Sep; 35(9):883-8. PubMed ID: 6480148 [TBL] [Abstract][Full Text] [Related]
8. Fundamentals of radioimmunotherapy. Eary JF Int J Rad Appl Instrum B; 1991; 18(1):105-8. PubMed ID: 2010294 [TBL] [Abstract][Full Text] [Related]
9. Dosimetry of Auger-electron-emitting radionuclides: report no. 3 of AAPM Nuclear Medicine Task Group No. 6. Humm JL; Howell RW; Rao DV Med Phys; 1994 Dec; 21(12):1901-15. PubMed ID: 7700197 [TBL] [Abstract][Full Text] [Related]
10. Radioimmunotherapy with alpha-particle emitting radionuclides. Zalutsky MR; Pozzi OR Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792 [TBL] [Abstract][Full Text] [Related]
11. Determination of the immunoreactivity of radiolabeled monoclonal antibodies: a theoretical analysis. Glatting G; Reske SN Cancer Biother Radiopharm; 2006 Feb; 21(1):15-21. PubMed ID: 16480327 [TBL] [Abstract][Full Text] [Related]
13. The use of radionuclides for tumor therapy. Fawwaz RA; Wang TS; Srivastava SC; Hardy MA Int J Rad Appl Instrum B; 1986; 13(4):429-36. PubMed ID: 3793498 [TBL] [Abstract][Full Text] [Related]
14. Antibody-based cancer treatment with ultra-short range Auger electron-emitting radionuclides: dual receptor and DNA targeting strategies. Karagiannis TC Hell J Nucl Med; 2007; 10(3):155-9. PubMed ID: 18084655 [TBL] [Abstract][Full Text] [Related]
15. An update on therapeutic uses of radiotracers in neoplastic disease. Spencer RP Semin Nucl Med; 1985 Jan; 15(1):21-7. PubMed ID: 3885398 [TBL] [Abstract][Full Text] [Related]
16. Basic immunology of antibody targeted radiotherapy. Wong JY Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S8-14. PubMed ID: 16979446 [TBL] [Abstract][Full Text] [Related]
17. Radionuclide therapy with iodine-125 and other auger-electron-emitting radionuclides: experimental models and clinical applications. Bodei L; Kassis AI; Adelstein SJ; Mariani G Cancer Biother Radiopharm; 2003 Dec; 18(6):861-77. PubMed ID: 14969599 [TBL] [Abstract][Full Text] [Related]
18. Can α-radioimmunotherapy increase efficacy for the systemic control of cancer? Allen BJ Immunotherapy; 2011 Apr; 3(4):455-8. PubMed ID: 21463184 [No Abstract] [Full Text] [Related]
19. The promise of targeted {alpha}-particle therapy. Mulford DA; Scheinberg DA; Jurcic JG J Nucl Med; 2005 Jan; 46 Suppl 1():199S-204S. PubMed ID: 15653670 [TBL] [Abstract][Full Text] [Related]
20. Future role of radiolabeled monoclonal antibodies in oncological diagnosis and therapy. Goldenberg DM Semin Nucl Med; 1989 Oct; 19(4):332-9. PubMed ID: 2678484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]